COMP <GO>
SILO vs ELAB // EV/EBITDA & P/E VALUATION
Silo Pharma Inc. (NASDAQ) VS. PMGC Holdings Inc. (NASDAQ) • 15-METRIC TALLY: SILO 3
— ELAB 0
■ METRIC PARITY
LAST: $1.25 (-6.72%) • MKT CAP: $2.4M
valuation
—
LAST: $2.64 (+2.72%) • MKT CAP: $2.1M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SILO VS. ELAB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SILO | ELAB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 38.60% | 31.40% | +7.20 | SILO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 0.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 3/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.1 | 25.9 | +8.22 | SILO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.4M | $2.1M | $241.8K | SILO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SILO REV | ELAB REV | SILO GROSS % | ELAB GROSS % | SILO FCF | ELAB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $72.1K | $590.1K | 38.6% | 31.4% | -$4.7M | -$6.4M |
| FY 2024 | $72.1K | $0 | 91.9% | — | -$3.8M | -$5.5M |
| FY 2023 | $72.1K | $1.7M | — | — | -$3.2M | -$4.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SILO // BETA —
ELAB // BETA —